Table 1

Patients characteristics and tumour parameters

Variable (N = 467)

Data


Age at Diagnosis, years

Mean and standard deviation

59 ± 13

Range

64 (Min 28; Max 92)

Tumour Size (cm)

Mean and standard deviation

3.110 cm ± 2.00 cm

Range

15.6 (Min 0.4; max 16)

T1: < 2 cm

101 (24.7%)

T2: 2-5 cm

245 (59.9%)

T3: > 5 cm

63 (15.4%)

Not assessed

58

Lymph Node Invasion

Present

207 (56.6%)

Absent

159 (43.4%)

Not assessed

101

Histological Grade

Grade I

81 (18.3%)

Grade II

135 (30.5%)

Grade III

227 (51.2%)

Not assessed

24

Oestrogen receptor

Positive

309 (66.5%)

Negative

156 (33.5%)

Not assessed

2

Progesterone Receptor

Positive

228 (48.9%)

Negative

238 (51.1%)

Not assessed

1

HER2

Positive

68 (14.7%)

Negative

395 (85.3%)

Not assessed

4

Nottingham Prognostic Index

NPI < 3.4

99 (24.4%)

3.4 ≤ NPI ≤ 5.4

188 (46.4%)

NPI > 5.4

118 (29.2%)

Not assessed

62

Molecular Subtype

Luminal

343 (73.6%)

HER2 Over-expressing

33 (7.1%)

Triple Negative

90 (19.3%)


Albergaria et al. BMC Cancer 2011 11:299   doi:10.1186/1471-2407-11-299

Open Data